{"id":43275,"date":"2025-10-15T12:16:28","date_gmt":"2025-10-15T04:16:28","guid":{"rendered":"https:\/\/flcube.com\/?p=43275"},"modified":"2025-10-15T12:16:28","modified_gmt":"2025-10-15T04:16:28","slug":"zhaoke-ophthalmology-secures-exclusive-indonesian-distribution-deal-for-nvk002-a-novel-atropine%e2%80%91based-myopia-treatment","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=43275","title":{"rendered":"Zhaoke Ophthalmology Secures Exclusive Indonesian Distribution Deal for NVK002, a Novel Atropine\u2011Based Myopia Treatment"},"content":{"rendered":"\n<p><strong>Zhaoke Ophthalmology Limited<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/6622:HKG\">HKG: 6622<\/a>), a leading China\u2011based ocular therapeutics company, announced today that it has entered into a distribution and supply agreement with <strong>PT Ferron Par Pharmaceuticals<\/strong> for the Indonesian market. The deal grants PT\u202fFerron exclusive rights to import, promote, distribute, market, and sell <strong>NVK002<\/strong>, Zhaoke\u2019s flagship topical atropine\u2011sulphate ophthalmic solution, in Indonesia.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-deal-highlights\">Deal Highlights<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Element<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Partner<\/strong><\/td><td>PT\u202fFerron Par Pharmaceuticals \u2013 Indonesia\u2019s leading pharma company<\/td><\/tr><tr><td><strong>Product<\/strong><\/td><td>NVK002 \u2013 investigational atropine\u2011sulphate topical solution<\/td><\/tr><tr><td><strong>Territory<\/strong><\/td><td>Indonesia (exclusive)<\/td><\/tr><tr><td><strong>Payments<\/strong><\/td><td>Up\u2011front payment + milestone\u2011based payments tied to sales &amp; regulatory achievements<\/td><\/tr><tr><td><strong>Target Population<\/strong><\/td><td>Children &amp; adolescents aged 3\u201117\u202fyears with myopia<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-what-is-nvk002\">What Is NVK002?<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Mechanism<\/strong> \u2013 Low\u2011concentration atropine\u2011sulphate formulated to inhibit myopia progression.<\/li>\n\n\n\n<li><strong>Innovation<\/strong> \u2013 Proprietary, preservative\u2011free formulation that overcomes the instability of conventional low\u2011dose atropine.<\/li>\n\n\n\n<li><strong>Shelf Life<\/strong> \u2013 Expected >\u202f24\u202fmonths under normal storage conditions.<\/li>\n\n\n\n<li><strong>Global Positioning<\/strong> \u2013 Among the most advanced atropine candidates worldwide, targeting the broadest age range (3\u201117\u202fyears).<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-significance\">Strategic Significance<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Market Expansion<\/strong> \u2013 Entry into Indonesia, the world\u2019s fourth\u2011largest eye\u2011health market, aligns with Zhaoke\u2019s global growth strategy.<\/li>\n\n\n\n<li><strong>Competitive Edge<\/strong> \u2013 Exclusive rights to a first\u2011in\u2011class, preservative\u2011free myopia solution with proven intellectual\u2011property protection.<\/li>\n\n\n\n<li><strong>Revenue Upside<\/strong> \u2013 Milestone payments linked to sales milestones and regulatory milestones provide upside potential for Zhaoke\u2019s valuation.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-about-zhaoke-ophthalmology\">About Zhaoke Ophthalmology<\/h2>\n\n\n\n<p>Zhaoke Ophthalmology Limited is a Hong\u202fKong\u2011listed biopharmaceutical company dedicated to discovering and commercialising innovative ocular therapeutics. Its pipeline spans refractive eye diseases, retinal disorders, and ocular surface diseases, supported by a strong regulatory and commercial platform.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-forward-looking-statements\">Forward\u2011Looking Statements<\/h2>\n\n\n\n<p>This release contains forward\u2011looking statements regarding the distribution agreement, future sales, and regulatory approvals. These statements are based on current expectations and are subject to risks and uncertainties.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Zhaoke Ophthalmology Limited (HKG: 6622), a leading China\u2011based ocular therapeutics company, announced today that it&#8230;<\/p>\n","protected":false},"author":1,"featured_media":43384,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[942,44,4384,166],"class_list":["post-43275","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-hkg-6622","tag-ophthalmology","tag-pt-ferron-par-pharmaceuticals","tag-zhaoke-ophthalmology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Zhaoke Ophthalmology Secures Exclusive Indonesian Distribution Deal for NVK002, a Novel Atropine\u2011Based Myopia Treatment - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Zhaoke Ophthalmology Limited (HKG: 6622), a leading China\u2011based ocular therapeutics company, announced today that it has entered into a distribution and supply agreement with PT Ferron Par Pharmaceuticals for the Indonesian market. The deal grants PT\u202fFerron exclusive rights to import, promote, distribute, market, and sell NVK002, Zhaoke\u2019s flagship topical atropine\u2011sulphate ophthalmic solution, in Indonesia.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=43275\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zhaoke Ophthalmology Secures Exclusive Indonesian Distribution Deal for NVK002, a Novel Atropine\u2011Based Myopia Treatment\" \/>\n<meta property=\"og:description\" content=\"Zhaoke Ophthalmology Limited (HKG: 6622), a leading China\u2011based ocular therapeutics company, announced today that it has entered into a distribution and supply agreement with PT Ferron Par Pharmaceuticals for the Indonesian market. The deal grants PT\u202fFerron exclusive rights to import, promote, distribute, market, and sell NVK002, Zhaoke\u2019s flagship topical atropine\u2011sulphate ophthalmic solution, in Indonesia.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=43275\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-15T04:16:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1501.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43275#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43275\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Zhaoke Ophthalmology Secures Exclusive Indonesian Distribution Deal for NVK002, a Novel Atropine\u2011Based Myopia Treatment\",\"datePublished\":\"2025-10-15T04:16:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43275\"},\"wordCount\":303,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43275#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1501.webp\",\"keywords\":[\"HKG: 6622\",\"Ophthalmology\",\"PT Ferron Par Pharmaceuticals\",\"Zhaoke Ophthalmology\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=43275#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43275\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=43275\",\"name\":\"Zhaoke Ophthalmology Secures Exclusive Indonesian Distribution Deal for NVK002, a Novel Atropine\u2011Based Myopia Treatment - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43275#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43275#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1501.webp\",\"datePublished\":\"2025-10-15T04:16:28+00:00\",\"description\":\"Zhaoke Ophthalmology Limited (HKG: 6622), a leading China\u2011based ocular therapeutics company, announced today that it has entered into a distribution and supply agreement with PT Ferron Par Pharmaceuticals for the Indonesian market. The deal grants PT\u202fFerron exclusive rights to import, promote, distribute, market, and sell NVK002, Zhaoke\u2019s flagship topical atropine\u2011sulphate ophthalmic solution, in Indonesia.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43275#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=43275\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43275#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1501.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1501.webp\",\"width\":1080,\"height\":608,\"caption\":\"Zhaoke Ophthalmology Secures Exclusive Indonesian Distribution Deal for NVK002, a Novel Atropine\u2011Based Myopia Treatment\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43275#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Zhaoke Ophthalmology Secures Exclusive Indonesian Distribution Deal for NVK002, a Novel Atropine\u2011Based Myopia Treatment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Zhaoke Ophthalmology Secures Exclusive Indonesian Distribution Deal for NVK002, a Novel Atropine\u2011Based Myopia Treatment - Insight, China&#039;s Pharmaceutical Industry","description":"Zhaoke Ophthalmology Limited (HKG: 6622), a leading China\u2011based ocular therapeutics company, announced today that it has entered into a distribution and supply agreement with PT Ferron Par Pharmaceuticals for the Indonesian market. The deal grants PT\u202fFerron exclusive rights to import, promote, distribute, market, and sell NVK002, Zhaoke\u2019s flagship topical atropine\u2011sulphate ophthalmic solution, in Indonesia.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=43275","og_locale":"en_US","og_type":"article","og_title":"Zhaoke Ophthalmology Secures Exclusive Indonesian Distribution Deal for NVK002, a Novel Atropine\u2011Based Myopia Treatment","og_description":"Zhaoke Ophthalmology Limited (HKG: 6622), a leading China\u2011based ocular therapeutics company, announced today that it has entered into a distribution and supply agreement with PT Ferron Par Pharmaceuticals for the Indonesian market. The deal grants PT\u202fFerron exclusive rights to import, promote, distribute, market, and sell NVK002, Zhaoke\u2019s flagship topical atropine\u2011sulphate ophthalmic solution, in Indonesia.","og_url":"https:\/\/flcube.com\/?p=43275","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-10-15T04:16:28+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1501.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=43275#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=43275"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Zhaoke Ophthalmology Secures Exclusive Indonesian Distribution Deal for NVK002, a Novel Atropine\u2011Based Myopia Treatment","datePublished":"2025-10-15T04:16:28+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=43275"},"wordCount":303,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=43275#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1501.webp","keywords":["HKG: 6622","Ophthalmology","PT Ferron Par Pharmaceuticals","Zhaoke Ophthalmology"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=43275#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=43275","url":"https:\/\/flcube.com\/?p=43275","name":"Zhaoke Ophthalmology Secures Exclusive Indonesian Distribution Deal for NVK002, a Novel Atropine\u2011Based Myopia Treatment - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=43275#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=43275#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1501.webp","datePublished":"2025-10-15T04:16:28+00:00","description":"Zhaoke Ophthalmology Limited (HKG: 6622), a leading China\u2011based ocular therapeutics company, announced today that it has entered into a distribution and supply agreement with PT Ferron Par Pharmaceuticals for the Indonesian market. The deal grants PT\u202fFerron exclusive rights to import, promote, distribute, market, and sell NVK002, Zhaoke\u2019s flagship topical atropine\u2011sulphate ophthalmic solution, in Indonesia.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=43275#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=43275"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=43275#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1501.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1501.webp","width":1080,"height":608,"caption":"Zhaoke Ophthalmology Secures Exclusive Indonesian Distribution Deal for NVK002, a Novel Atropine\u2011Based Myopia Treatment"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=43275#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Zhaoke Ophthalmology Secures Exclusive Indonesian Distribution Deal for NVK002, a Novel Atropine\u2011Based Myopia Treatment"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1501.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43275","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=43275"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43275\/revisions"}],"predecessor-version":[{"id":43383,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43275\/revisions\/43383"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/43384"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=43275"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=43275"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=43275"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}